Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: Association with progression and angiogenesis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Prostate

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pros.20028PMID 14991865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosomal Deletions and Tumor Suppressor Genes in Prostate Cancer

  2004cited by this paper
• Genetic markers useful for distinguishing between organ‐confined and locally advanced prostate cancer

  2003cited by this paper
• Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion

  2003cited by this paper
• Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization.

  2002cited by this paper
• Genetic changes in stage pT2N0 prostate cancer studied by comparative genomic hybridization

  2002influential reference
• Microvessel density in prostate carcinoma

  2002cited by this paper
• Chromosomal changes in incidental prostatic carcinomas detected by comparative genomic hybridization.

  2002cited by this paper
• Deletion of chromosomal region 6q14‐16 in prostate cancer

  2002cited by this paper
• Resolution of genotypic heterogeneity in prostate tumors using polymerase chain reaction and comparative genomic hybridization on microdissected carcinoma and prostatic intraepithelial neoplasia foci.

  2002cited by this paper
• An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.

  2001cited by this paper
• Chromosomal changes during development and progression of prostate adenocarcinomas

  2001cited by this paper
• Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization *

  2001cited by this paper
• Chromosomal changes in locally recurrent, hormone-refractory prostate carcinomas by karyotyping and comparative genomic hybridization.

  2001cited by this paper
• Genetic changes in familial prostate cancer by comparative genomic hybridization

  2001cited by this paper
• Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer

  2000cited by this paper
• Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers.

  2000cited by this paper
• Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization.

  2000cited by this paper
• Genetic alterations in microdissected prostate cancer cells by comparative genomic hybridization

  2000cited by this paper
• Identification of Genetic Markers for Prostatic Cancer Progression

  2000cited by this paper
• Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer

  1999influential reference
• Identification of a 1‐cM region of common deletion on 13q14 associated with human prostate cancer

  1999cited by this paper
• Three distinct regions of allelic loss at 13q14, 13q21‐22, and 13q33 in prostate cancer

  1999cited by this paper
• Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3

  1999cited by this paper
• Allelic loss on chromosome 6Q in primary prostate cancer

  1999cited by this paper
• Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.

  1999cited by this paper
• Whole genome amplification and molecular genetic analysis of DNA from paraffin-embedded prostate adenocarcinoma tumor tissue.

  1999cited by this paper
• A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans.

  1998cited by this paper
• Degenerate oligonucleotide-primed PCR (DOP-PCR): evaluation of its reliability for screening of genetic alterations in neoplasia.

  1998cited by this paper
• Genetic alterations in hormone-refractory recurrent prostate carcinomas.

  1998cited by this paper
• Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types

  1998cited by this paper
• Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results.

  1998cited by this paper
• Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization

  1998cited by this paper
• Interpreting simple STR mixtures using allele peak areas.

  1998cited by this paper
• Identification of two distinct deleted regions on chromosome 13 in prostate cancer

  1998cited by this paper
• CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.

  1998cited by this paper
• Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.

  1997cited by this paper
• BRCA2 mutation in Icelandic prostate cancer patients

  1997cited by this paper
• Allelic loss on chromosome 13q in human prostate carcinoma.

  1997cited by this paper
• Vascular density is a predictor of cancer‐specific survival in prostatic carcinoma

  1997cited by this paper
• A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profiles.

  1997cited by this paper
• Optimizing DOP‐PCR for universal amplification of small DNA samples in comparative genomic hybridization

  1997cited by this paper
• Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in gleason sum 5 to 7 adenocarcinoma of the prostate

  1997cited by this paper
• Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.

  1996cited by this paper
• Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas.

  1996cited by this paper
• Distinct regions of allelic loss on 13q in prostate cancer.

  1996cited by this paper
• Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas.

  1996cited by this paper
• Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.

  1996cited by this paper
• A gene on 6q 14-21 restores senescence to immortal ovarian tumor cells.

  1996cited by this paper
• Allelic imbalance of chromosome 6q in ovarian tumours.

  1995cited by this paper
• Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

  1995influential reference
• Computer image analysis of comparative genomic hybridization.

  1995cited by this paper
• Clinical Applications of Research on Angiogenesis

  1995cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

  1995cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization

  1995cited by this paper
• Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas

  1995cited by this paper
• Retinoblastoma gene mutations in primary human prostate cancer

  1995cited by this paper
• Both v-Ha-Ras and v-Raf Stimulate Expression of the Vascular Endothelial Growth Factor in NIH 3T3 Cells (*)

  1995cited by this paper
• In vivo amplification of the androgen receptor gene and progression of human prostate cancer

  1995cited by this paper
• Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

  1994cited by this paper
• Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.

  1994cited by this paper
• Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

  1994cited by this paper
• Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

  1994cited by this paper
• Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer

  1994cited by this paper
• Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

  1994cited by this paper
• Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

  1994cited by this paper
• Angiogenesis

  1993cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• The TNM classification of prostate cancer

  1992cited by this paper
• Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

  1992cited by this paper
• Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.

  1991cited by this paper
• Induction of angiogenesis during the transition from hyperplasia to neoplasia

  1989cited by this paper

• The Emerging Predictive and Prognostic Role of Aggressive-Variant-Associated Tumor Suppressor Genes Across Prostate Cancer Stages

  2025cites this paper
• Blood and urine-based biomarkers in prostate cancer: Current advances, clinical applications, and future directions

  2025cites this paper
• Deletion of 2q21 Characterizes a Small Subgroup of Aggressive ERGNegative Prostate Cancers

  2021cites this paper
• 13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancer

  2018cites this paper
• Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer

  2018cites this paper
• Identification of the genetic alterations in prostate cancer metastases

  2017cites this paper
• DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer

  2016cites this paper
• Bedeutung und Charakterisierung der 6q-Deletion beim Prostatakarzinom

  2016influential citation
• Cytogenetic analysis of prostate carcinoma patients

  2013cites this paper
• Expression and epigenetic regulation of imprinted genes in prostate cancer

  2013cites this paper
• Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance—promising for molecular staging of prostate cancers

  2013cites this paper
• A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility

  2011cites this paper
• The role of the Eph and ephrin proteins in prostate cancer

  2011cites this paper
• Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells

  2011cites this paper
• Digital karyotyping reveals probable target genes at 7q21.3 locus in hepatocellular carcinoma

  2011cites this paper
• PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.

  2010cites this paper
• Pharmacologyonline 1: 964-978 (2010) ewsletter Patharajan and Karthikeyan 964 I TEGRATIO OF I DIA TRADITIO AL HERBAL MEDICI ES WITH MODER

  2010cites this paper
• Identification of Chromosome Aberrations among Benign Prostatic Hyperplasia Patients in Tamilnadu, Southern India

  2010cites this paper
• ITEGRATIOOF IDIATRADITIOAL HERBAL MEDICIES WITH MODER TECHOLOGIESAOVERVIEW

  2010cites this paper
• Genetic profile identification in clinically localized prostate carcinoma.

  2009cites this paper
• The Prostate 68 : 1496 ^ 1509 ( 2008 ) SimultaneouslyDetectionofGenomic and ExpressionAlterations in ProstateCancer UsingcDNAMicroarray

  2008cites this paper
• Expression changes of CAV1 and EZH2, located on 7q31 approximately q36, are rarely related to genomic alterations in primary prostate carcinoma.

  2008cites this paper
• Detection of Novel Amplicons in Prostate Cancer by Comprehensive Genomic Profiling of Prostate Cancer Cell Lines Using Oligonucleotide-Based ArrayCGH

  2007cites this paper
• Gain of chromosome X in prostatic atrophy detected by CGH and FISH analyses

  2007cites this paper
• DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies

  2007cites this paper
• Identification of PFTAIRE protein kinase 1, a novel cell division cycle‐2 related gene, in the motile phenotype of hepatocellular carcinoma cells

  2007cites this paper
• Evaluation of Whole Genome Amplification Protocols for Array and Oligonucleotide CGH

  2007cites this paper
• An improved in vitro model to characterize invasive growing cancer cells simultaneously by function and genetic aberrations.

  2007cites this paper
• Charakterisierung einer neuen Amplifikationseinheit auf Chromosom 3q25-q26 beim Prostatakarzinom mit Hilfe molekular-zytogenetischer und quantitativer PCR-Techniken

  2007cites this paper
• Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array

  2006cites this paper
• Identifizierung und Charakterisierung metastatischer Vorläuferzellen aus dem Knochenmark beim Prostatakarzinom

  2006cites this paper
• DNA Microarrays in Herbal Drug Research

  2006cites this paper
• Genomic and Expression Analysis of the 3q25-q26 Amplification Unit Reveals TLOC1/SEC62 as a Probable Target Gene in Prostate Cancer

  2006cites this paper
• Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen.

  2006cites this paper
• Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers

  2006cites this paper
• Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma

  2006cites this paper
• Characterization of Frequently Deleted 6q Locus in Prostate Cancer

  2006cites this paper
• Estimating cancer survival and clinical outcome based on genetic tumor progression scores

  2005cites this paper
• Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer

  2005cites this paper